Results 1 to 10 of about 171,828 (231)

DUOX2 Expression Is Increased in Barrett Esophagus and Cancerous Tissues of Stomach and Colon [PDF]

Gastroenterology Research and Practice, 2016
Aim. To detect the expression of dual oxidase (DUOX) 2 in Barrett esophagus, gastric cancer, and colorectal cancer (CRC). Materials and Methods. The endoscopic biopsies were collected from patients with Barrett esophagus, while the curative resection ...
Ran Qi, Yunfeng Zhou, Xiaozhen Li, Hong Guo, Lei Gao, Lijuan Wu, Yufeng Wang, Qiang Gao   +7 more
doaj   +2 more sources

Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report

Thoracic Cancer, 2022
Most primary esophageal adenocarcinomas arise from the Barrett epithelium of the distal esophagus. Thus, cancer developing from the ectopic gastric mucosa (EGM) of the proximal esophagus is extremely rare. Furthermore, recurrent adenocarcinoma at the EGM
Nao Kitasaki, Yoichi Hamai, Toru Yoshikawa, Manabu Emi, Tomoaki Kurokawa, Ryosuke Hirohata, Manato Ohsawa, Morihito Okada   +7 more
doaj   +1 more source

15 Years after Sleeve Gastrectomy: Gastroscopies, Manometries and 24h pH-metries in a Long-term Follow-up – A Multicenter Study

Obesity Facts, 2022
INTRODUCTION: Sleeve Gastrectomy (SG) is the most common bariatric operation with over 340.000 procedures per year. There are only few studies presenting follow-up results >10 years in the literature today.
Daniel Moritz Felsenreich, Evi Artemiou, Lukas Wintersteller, Julia Jedamzik, Jakob Eichelter, Lisa Gensthaler, Christoph Bichler, Christoph Sperker, Philipp Beckerhinn, Ivan Kristo, Felix Benedikt Langer, Gerhard Prager   +11 more
doaj   +1 more source

Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases

The Turkish Journal of Gastroenterology, 2014
Background/Aims: Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is an oncofetal protein with vital function during human embryogenesis in terms of cellular growth and migration.
Behrang Kazeminezhad, Seyed Abbas Mirafsharieh, Kamran Dinyari, Davood Azizi, Abdolali Ebrahimi   +4 more
doaj   +1 more source

Barrett's Esophagus [PDF]

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022
Barrett’s esophagus (BE) is caused by metaplasia of squamous epithelium into columnar epithelium, mainly in the lower esophagus. Updates have been made in the etiology, diagnosis and treatment of BE since its first report as an ulcerative lesion in the ...
Yong Kang Lee
doaj   +1 more source

Prevalence of Barrett's esophagus: An observational study from a gastroenterology clinic

Revista de Gastroenterología de México (English Edition), 2017
Introduction and aims: Barrett's esophagus is a condition that predisposes to esophageal adenocarcinoma. Our aim was to establish the prevalence of Barrett's esophagus at our center, as well as determine its associated factors.
J.L. Herrera Elizondo, R. Monreal Robles, D. García Compean, E.I. González Moreno, O.D. Borjas Almaguer, H.J. Maldonado Garza, J.A. González González   +6 more
doaj   +1 more source

Metaplasia intestinal especializada de esôfago distal na doença do refluxo gastroesofágico: prevalência e aspectos clínico-epidemiológicos Specialized intestinal metaplasia of distal esophagus in the gastroesophageal reflux disease: prevalence and clinical-demographic features

Arquivos de Gastroenterologia, 2003
RACIONAL: A metaplasia intestinal especializada pode ser classificada, de acordo com os achados endoscópicos e histológicos, em Barrett longo, Barrett curto e metaplasia intestinal da cárdia.
Leiber C. Caum, Sérgio L. Bizinelli, Júlio César Pisani, Heda Maria Barska dos Santos Amarantes, Sérgio O. Ioshii, Eliane R. Carmes   +5 more
doaj   +1 more source

A tiny lesion arising within Barrett’s esophagus

The Turkish Journal of Gastroenterology, 2020
Cite this article as: Pugliese F, Bonato G, Dioscoridi L, et al. A tiny lesion arising within Barrett’s esophagus. Turk J Gastroenterol 2020; 5: 410-2.
Francesco Pugliese, Giulia Bonato, Lorenzo Dioscoridi, Marcello Cintolo, Maria Costanza Aquilano, Edoardo Forti, Aurora Giannetti, Angelo Italia, Massimiliano Mutignani   +8 more
doaj   +1 more source

Barrett's Esophagus

Gastroenterology Clinics of North America, 2008
Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma. Since most patients with Barrett's esophagus are undiagnosed and patients present with advanced adenocarcinoma de novo, prognosis for this disease remains poor. To identify those people with Barrett's esophagus who are at particular risk many new technologies are ...
Bird-Lieberman, E, Fitzgerald, R
openaire   +3 more sources

Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?

The Turkish Journal of Gastroenterology, 2017
Besides reducing the reflux symptoms, the benefit of proton pump inhibitors (PPI) in the treatment of Barrett's esophagus (BE) is not exactly known.
Hakan Akın, Yücel Aydın
doaj   +1 more source